FDA Drug recall D-832-2013
Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princ…
- FDA Drug
- Class I
- terminated
- Published 2013-08-14
On 2013-08-14 the FDA classified a Class I recall of Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princ… by Sandoz, citing presence of Particulate Matter: Found during examination of retention samples.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-832-2013 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-05-20 |
| Published | 2013-08-14 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Sandoz |
| Distribution | US |
Product
Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01.
Reason
Presence of Particulate Matter: Found during examination of retention samples.
Identifiers
| code_info | Lot #: CL0996, Exp 12/13; and CJ4948, Exp 05/13 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-832-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.